Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail
-

Funding and Support

 

Misuse and Abuse of DEA Schedule II-IV Opioid Analgesic Drugs: Researching Strategies to Ensure Safe Use and Reduce Preventable Harm

Read the details of the announcement (RFA-FD-12-0050)disclaimer icon

 

The following three cooperative agreements were awarded in fiscal year 2012:

  • Maimonides Medical Center, Brooklyn, New York
    Analysis of PDMP Data Assessing Impact of State Intervention on High-Risk Prescribers
     
  • Oregon Health and Science University, Portland, Oregon
    Reducing Prescription Opioid Misuse and Abuse with Urine Drug Testing
     
  • University of Wisconsin, Madison, Wisconsin
    The Prescriber Opioid Risk Reduction Strategies (PORRS) Study

 

Novel Interventions and Collaborations to Improve the Safe Use of Medications

Read the details of the announcement (RFA-FD-11-024)disclaimer icon

 

The following ten cooperative agreements were awarded in fiscal year 2011:

  • Children’s Mercy Hospital, Kansas City, Missouri
    Ensuring medication safety in pediatric emergencies
     
  • Georgia Medical Care Foundation, Atlanta, Georgia
    Improving the safe use of medications by patients with diabetes
     
  • Kaiser Foundation Research Institute, Oakland, California
    Predicting the risk of C. difficile infection to improve fluoroquinolone use
     
  • National Foundation for Celiac Awareness, Ambler, Pennsylvania
    Gluten in Medication: Qualifying the extent of exposure to people with celiac disease and identifying a hidden and preventable cause of an adverse drug event
     
  • Stanford University, Stanford, California
    Impact of the unapproved drug initiative on colchicine use
     
  • University of Alabama, Birmingham, Birmingham, Alabama
    Reducing preventable harm triggered by pharmaceutical spam
     
  • University of Michigan, Ann Arbor, Michigan
    A statewide pediatric safety collaboration to standardize compounded oral liquids
     
  • University of Pittsburgh, Pittsburgh, Pennsylvania
    Improving the safe use of isotretinoin
     
  • University of Rhode Island, Kingston, Rhode Island
    Promoting safe use of medications by providing medication education to seniors receiving meals on wheels
     
  • University of South Carolina Research Foundation, Columbia, South Carolina
    South Carolina opioid safety initiative (SCOSI)

 

-
-